Can Intercept Make it to the Finishing Line in NASH?
Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) is a biopharmaceutical Company aiming to create novel therapeutics for the treatment of progressive non-viral liver diseases. The Company’s...
Coverage
- All
- Beauty
- Biotechnology
- Cannabis
- Communications
- Education
- Energy
- Entertainment
- Environment
- ETFs
- Finance
- Fitness
- Food and Beverage
- Healthcare
- Hospitality
- Insider Trading
- Investing Ideas
- Macro
- Market Insight
- Miscellaneous
- Power
- Real Estate
- Retail
- Sectors
- Security
- Startups
- Technologies
- Trending
- Uncategorized
Lemonade Inc: A Buying Opportunity or All Hype?
Lemonade, Inc. (NYSE: LMND) offers AI-powered insurance services that encompass renters, homeowners, car, pets and life insurance. The Company’s insurance carriers in the...
5 Biotech Stocks with Major Upcoming Catalysts
Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these companies bring new and highly differentiated approaches, advanced scientific...
Will Resmetirom Prove to be a Gamechanger in NASH?
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company, is developing novel therapeutics that target a specific thyroid hormone receptor pathway in the...
4 Technology Stocks to Buy for Higher Returns!
Technology Industry has been focused on minimizing the impact of COVID-19 and marching ahead with its innovations and breakthroughs, be it critical components...
Why C3.ai is a Risky But Must Watch Investment!
C3.ai, Inc. (NYSE: AI) is a leading provider of enterprise software that enables digital transformation and building of enterprise-scale AI applications. The Company...
5 Reasons to Add Sierra Oncology to Your Portfolio
Sierra Oncology, Inc. (NASDAQ: SRRA) is focussed on creating novel targeted therapies that address large unmet needs in rare forms of cancer. The...
Emerging Paradigms in treatment of Melanoma!
Melanoma, a form of skin cancer, accounts for about 1% of skin cancers but is responsible for over 7,650 deaths every year as...
7 Reasons to Put Adicet Bio on your Watchlist!
Adicet Bio, Inc. (NASDAQ: ACET) is a biotechnology Company working on bringing allogeneic gamma delta T cell therapies for cancer and other therapies....
